Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 55 results for "for merck"

P&G's vitamin boost could signal more to come

DON/CHICAGO (Reuters) - Procter & Gamble's $4.2 billion deal for Merck's vitamin and supplements business is the latest example of a major consumer company stocking up on health-related products. The U.S.-based maker of Tide detergent and Gillette razors ... Business Standard, 2 days ago

15 images for for merck

Business Standard, 2 days ago
Business Standard, 2 days ago
Business Standard, 3 days ago
Business Standard, 1 week ago
Business Standard, 3 weeks ago
Business Standard, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard

As part of $4.2-bn global deal, P&G to acquire Merck India for Rs 12.9 bn

Deal part of its $4.2 billion global acquisition of German drug maker's consumer health business Aneesh Phadnis & Viveat Susan Pinto | Mumbai Last Updated at April 19, 2018 21:17 IST Photo: Reuters Procter & Gamble, the world’s largest consumer goods ...
 Business Standard2 days ago P&G to acquire consumer health unit of Germany's Merck for about $4.21 bn  Business Standard3 days ago Merck to sell consumer health business to P&G for $4.2 bn  Nerve2 days ago
Business Standard

Merck zooms 19% on open offer by Procter & Gamble Overseas India

stock surged 19% to Rs 1,795, also its record high on the BSE after the Procter & Gamble Overseas India makes mandatory open offer at price of Rs 1,500.36 per share SI Reporter | Mumbai Last Updated at April 19, 2018 10:19 IST Stock brokers react to the ...
 Business Standard3 days ago
Money Control

Strides Shasun gains 2% on USFDA approval for antihistamine drug

Cyproheptadine hydrochloride tablets is a generic version of Periactin tablets of Merck Co Inc.
 Money Control1 week ago Strides Shasun arm gets USFDA nod for allergy relief drug  Business Standard1 week ago
Business Standard

Merck Foundation invites applications to Merck Hypertension and Diabetes Awards 2018

Merck Foundation, the philanthropic arm of Merck KGaA Germany, announced the call for application for Merck Diabetes and Hypertension awards 2018, across the African and Asian Universities through its Merck Capacity Advancement Program with the aim to ...
 Business Standard1 week ago Frank Stangnberg-Haverkamp discusses Merck Foundation's commitment towards Niger with President Issoufou  Business Standard1 month ago Merck Foundation, African First Ladies Organisation sign MoU, to build cancer and fertility care capacity  Business Standard2 months ago

Merck appoints Milind Thatte as MD

Drug firm Merck Ltd today said Milind Thatte has been appointed as managing director of the company effective from April 1, 2018.The company's board today has appointed Milind Thatte, General Manager Healthcare, as an additional director and managing director ...
 Business Standard3 weeks ago

Massachusetts court - Merck can be sued over generic drug injury

BOSTON (Reuters) - Massachusetts' top court on Friday opened the door for consumers to sue Merck & Co Inc and other makers of brand-name drugs over injuries blamed not on their own medications but on generic versions of their treatments made by other ...
 Business Standard1 month ago Massachusetts court: Merck can be sued over generic drug injury  Reuters1 month ago

Hold Merck; target of Rs 1080: Centrum

Centrum Research is bullish on Merck has recommended hold rating on the stock with a target price of Rs 1080 in its research report dated February 26, 2018.
 Money Control1 month ago
Money Control

Merck, KSB Pumps, ITD Cementation up 3-5% on strong Q3 numbers

Merck has posted 42 percent increase in its Q3FY18 net profit at Rs 27 crore and revenue was up 22 percent at Rs 304 crore.
 Money Control1 month ago

Penetration of bio-similars market is low in India: Merck#39;s Udit Batra

CNBC-TV18#39;s Ekta Batra caught up with Udit Batra, Member of the Merck Executive Board and CEO, Life Sciences and quizzed him on where India stands when it comes to bio-similar investments and how India can fill the gap.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less